750 LEXINGTON AVENUE
NEW YORK NY 10022
Business Phone: 212-531-5965
• NEW YORK, NY How do I update this listing?
Keryx Biopharmaceuticals is based out of New York. Acquires, develops and commercializes novel pharmaceutical products for the treatment of life-threatening diseases. As of Dec. 31, 2005, the company's lead product candidates were Sulonex for the treatment of diabetic nephropathy and KRX-0401 for the treatment of multiple forms of cancer.Whalewisdom has at least 232 Form 4 filings The firm has no submitted 13F filings and does not appear to be an investment advisor.